The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel. The FDA approved the drug, Erelzi, known also as etanercept-szzs, for multiple inflammatory conditions including rheumatoid ... Reuters, 1 month ago
Novartis AG said a late-stage study showed its oral, once-daily BAF312, or siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis. The Phase III EXPAND study, the largest randomized, controlled study in secondary ...Reuters, 2 months ago
Pfizer Inc.'s version, called Inflectra, will hit pharmacies in late November. Trenton: Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade. Pfizer Inc.'s version, ...Asian Age, 1 week ago
Sun Pharmaceutical Industries today said it has entered into a distribution pact with Mitsubishi Tanabe Pharma Corporation to market 14 prescription drugs, which it acquired from Novartis AG for $293 million in March this year. The Mumbai-based company said ...The Telegraph, 1 month ago
Stocks rose, with the benchmark gauge erasing a weekly decline, as overseas investors extended their purchases of local assets. State Bank of India rallied to an eight-month high after it posted a smaller-than-expected rise in soured debt. Axis Bank increased ...The Financial Chronicle, 2 months ago
on your WebpageAdd Widget >Get your members hooked!